A federal judge in Florida has appointed 26 lawyers to spearhead the lawsuits filed over heartburn medication Zantac, with nearly half of them women and at least four minority attorneys.
U.S. District Judge Robin Rosenberg, who held two days of leadership interviews with 62 attorneys via teleconference this week, emphasized the diversity of the team, which will oversee about 230 lawsuits against the makers and sellers of Zantac. The team includes four co-lead counsel, 15 members of a plaintiffs’ steering committee and, in an unusual move, the judge created a “leadership development committee” that will provide “mentorship and experience” to five lawyers who applied.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
